Investor Update

Basel, 02 December 2010

Reminder: Invitation to Late-stage pipeline event - Thursday December 9th, 2010

The Roche Investor Relations team would like to invite you to a Late-stage pipeline event that will take place in London, 9 December 2010, starting at 09:00 GMT at the London Stock Exchange.

The event will provide an opportunity to discuss the clinical data and the development plans for the late-stage compounds in the Roche oncology and CNS development pipeline. The update will focus on the data presented at this year’s European Society for Medical Oncology (ESMO), European committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), International Melanoma Congress, American Society of Hematology (ASH) and the American College of Neuropsychopharmacology (ACNP).

The presenters will include:

  • Hal Barron, Head of Global Product Development, Chief Medical Officer and
  • Eugene Tierney, Global Product Strategy TA Head, CNS

Meeting information

(download to my calendar)

Date: December 9, 2010

8:15 Registration and buffet breakfast
9:00 Meeting start
11:00 Meeting end

Venue: London Stock Exchange, Theatre room, 10 Paternoster Square, London UK (map)

Please make sure to have an identification document and allow enough time to go through the LSE security check.

To register for the event, please follow the link.

This presentation can be viewed through a live video webcast accessed via

Alternatively, dial in to the conference 10-15 min prior to the scheduled start using the following numbers (listen-only mode, no live-access to speakers):
+41 (0) 91 610 56 00 (Europe and ROW)
+44 (0) 203 059 58 62 (UK)
+1 (1) 866 291 41 66 (USA Toll Free)

A replay of the call will be available one hour after the conference call, for 48 hours. Access is by dialing:
+41 (0) 91 612 43 30 (Europe and ROW) or
+44 (0) 207 108 62 33 (UK)
+1 (1) 866 416 25 58 (USA)
and will be asked to enter the ID 16893 followed by the # sign.

A replay of the webcast will be available on demand at